Vivek Subbiah: You’re all going for gold

Vivek Subbiah shared a post on LinkedIn:

“Thrilled to see all our staff in the clinical trials clinic embody the Olympic spirit to eradicate cancer.

Huge thanks to all the clinical trials teams Sarah Cannon Research Institute working tirelessly behind the scenes – you’re all going for gold.

OUR STAFF TAKES THE GOLD.”

Source: Vivek Subbiah/LinkedIn

Vivek Subbiah is the Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute (USA). He is the former Executive Director of Oncology Research and former Associate Professor in the Department of Investigational Cancer Therapeutics at the MD Anderson Cancer He focuses on translational cancer research and the design and implementation of early-phase biomarker-driven clinical trials. His work specifically targets antibody-drug conjugates, radiopharmaceuticals, immunoconjugates, and basket trials